Health
newsGP – Mixed response to latest Solidarity trial COVID findings – RACGP
No therapeutics in the trial – including remdesivir – were found to affect on mortality or illness duration, but some say there is hope.
News
No therapeutics in the trial – including remdesivir – were found to affect on mortality or illness duration, but some say there is hope.
While the results were disappointing, some experts say more detailed research is required. (Image: AAP)
Pre-print interim results from Solidarity, the world’s largest randomised control trial on COVID-19 therapeutics, indicate that remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens have little or no effect on 28-day mortality or…
-
General7 hours agoPoliticians asked how to Trump-proof Australia’s fragile economy on Q+A
-
Business20 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News19 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business24 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?